FIELD: medicine, allergology. SUBSTANCE: method involves administration in patient a pharmaceutical composition comprising from about 0.005 to about 1.0 mg of heparins with ultralow molecular mass per kg weight of patient body in each dose where mean molecular mass of indicated heparins with ultralow molecular mass is from about 1 000 to about 3 000 Da. Invention can be used for treatment of patient with allergic responses at the late stage and inflammatory diseases also. EFFECT: enhanced effectiveness of treatment. 63 cl, 1 tbl, 28 dwg, 4 ex
Authors
Dates
2003-08-10—Published
1998-08-04—Filed